866-997-4948(US-Canada Toll Free)

United States Gastric Cancer Drug Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Gastric Cancer

No. of Pages : 109 Pages

Notes:
Sales, means the sales volume of Gastric Cancer Drug
Revenue, means the sales value of Gastric Cancer Drug

This report studies sales (consumption) of Gastric Cancer Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Hoffmann-La Roche
Eli-lilly
Sanofi
Otsuka Holdings
Novartis
Amgen
Boston Biomedical
AROG Pharmaceuticals
ARIAD Pharmaceuticals
Roche
Merck
Eli Lilly
AB Science
Bayer HealthCare
Boehringer Ingelheim
Bristol-Myers Squibb
Five Prime
BIND Therapeutics
Ipsen Biopharmaceuticals
Eddingpharm

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Gastric Cancer Drug in each application, can be divided into
Application 1
Application 2
 

Table of Contents

United States Gastric Cancer Drug Market Report 2017
1 Gastric Cancer Drug Overview
1.1 Product Overview and Scope of Gastric Cancer Drug
1.2 Classification of Gastric Cancer Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of Gastric Cancer Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Gastric Cancer Drug (2012-2022)
1.4.1 United States Gastric Cancer Drug Sales and Growth Rate (2012-2022)
1.4.2 United States Gastric Cancer Drug Revenue and Growth Rate (2012-2022)

2 United States Gastric Cancer Drug Competition by Manufacturers
2.1 United States Gastric Cancer Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Gastric Cancer Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Gastric Cancer Drug Average Price by Manufactures (2015 and 2016)
2.4 Gastric Cancer Drug Market Competitive Situation and Trends
2.4.1 Gastric Cancer Drug Market Concentration Rate
2.4.2 Gastric Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Gastric Cancer Drug Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Gastric Cancer Drug Sales and Market Share by States (2012-2017)
3.2 United States Gastric Cancer Drug Revenue and Market Share by States (2012-2017)
3.3 United States Gastric Cancer Drug Price by States (2012-2017)

4 United States Gastric Cancer Drug Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Gastric Cancer Drug Sales and Market Share by Type (2012-2017)
4.2 United States Gastric Cancer Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Gastric Cancer Drug Price by Type (2012-2017)
4.4 United States Gastric Cancer Drug Sales Growth Rate by Type (2012-2017)

5 United States Gastric Cancer Drug Sales (Volume) by Application (2012-2017)
5.1 United States Gastric Cancer Drug Sales and Market Share by Application (2012-2017)
5.2 United States Gastric Cancer Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Gastric Cancer Drug Manufacturers Profiles/Analysis
6.1 Hoffmann-La Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Gastric Cancer Drug Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Hoffmann-La Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Eli-lilly
6.2.2 Gastric Cancer Drug Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Eli-lilly Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.2 Gastric Cancer Drug Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Otsuka Holdings
6.4.2 Gastric Cancer Drug Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Otsuka Holdings Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Novartis
6.5.2 Gastric Cancer Drug Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novartis Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Amgen
6.6.2 Gastric Cancer Drug Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Amgen Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Boston Biomedical
6.7.2 Gastric Cancer Drug Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Boston Biomedical Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 AROG Pharmaceuticals
6.8.2 Gastric Cancer Drug Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 AROG Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 ARIAD Pharmaceuticals
6.9.2 Gastric Cancer Drug Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 ARIAD Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Roche
6.10.2 Gastric Cancer Drug Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Merck
6.12 Eli Lilly
6.13 AB Science
6.14 Bayer HealthCare
6.15 Boehringer Ingelheim
6.16 Bristol-Myers Squibb
6.17 Five Prime
6.18 BIND Therapeutics
6.19 Ipsen Biopharmaceuticals
6.20 Eddingpharm

7 Gastric Cancer Drug Manufacturing Cost Analysis
7.1 Gastric Cancer Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastric Cancer Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Gastric Cancer Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastric Cancer Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Gastric Cancer Drug Market Forecast (2017-2022)
11.1 United States Gastric Cancer Drug Sales, Revenue Forecast (2017-2022)
11.2 United States Gastric Cancer Drug Sales Forecast by Type (2017-2022)
11.3 United States Gastric Cancer Drug Sales Forecast by Application (2017-2022)
11.4 Gastric Cancer Drug Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source
 

List of Table

List of Tables and Figures

Figure Picture of Gastric Cancer Drug
Table Classification of Gastric Cancer Drug
Figure United States Sales Market Share of Gastric Cancer Drug by Type in 2015
Table Application of Gastric Cancer Drug
Figure United States Sales Market Share of Gastric Cancer Drug by Application in 2015
Figure United States Gastric Cancer Drug Sales and Growth Rate (2012-2022)
Figure United States Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Table United States Gastric Cancer Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Gastric Cancer Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gastric Cancer Drug Sales Share by Manufacturers
Figure 2016 Gastric Cancer Drug Sales Share by Manufacturers
Table United States Gastric Cancer Drug Revenue by Manufacturers (2015 and 2016)
Table United States Gastric Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Gastric Cancer Drug Revenue Share by Manufacturers
Table 2016 United States Gastric Cancer Drug Revenue Share by Manufacturers
Table United States Market Gastric Cancer Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Gastric Cancer Drug Average Price of Key Manufacturers in 2015
Figure Gastric Cancer Drug Market Share of Top 3 Manufacturers
Figure Gastric Cancer Drug Market Share of Top 5 Manufacturers
Table United States Gastric Cancer Drug Sales by States (2012-2017)
Table United States Gastric Cancer Drug Sales Share by States (2012-2017)
Figure United States Gastric Cancer Drug Sales Market Share by States in 2015
Table United States Gastric Cancer Drug Revenue and Market Share by States (2012-2017)
Table United States Gastric Cancer Drug Revenue Share by States (2012-2017)
Figure Revenue Market Share of Gastric Cancer Drug by States (2012-2017)
Table United States Gastric Cancer Drug Price by States (2012-2017)
Table United States Gastric Cancer Drug Sales by Type (2012-2017)
Table United States Gastric Cancer Drug Sales Share by Type (2012-2017)
Figure United States Gastric Cancer Drug Sales Market Share by Type in 2015
Table United States Gastric Cancer Drug Revenue and Market Share by Type (2012-2017)
Table United States Gastric Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastric Cancer Drug by Type (2012-2017)
Table United States Gastric Cancer Drug Price by Type (2012-2017)
Figure United States Gastric Cancer Drug Sales Growth Rate by Type (2012-2017)
Table United States Gastric Cancer Drug Sales by Application (2012-2017)
Table United States Gastric Cancer Drug Sales Market Share by Application (2012-2017)
Figure United States Gastric Cancer Drug Sales Market Share by Application in 2015
Table United States Gastric Cancer Drug Sales Growth Rate by Application (2012-2017)
Figure United States Gastric Cancer Drug Sales Growth Rate by Application (2012-2017)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hoffmann-La Roche Gastric Cancer Drug Sales Market Share (2012-2017)
Table Eli-lilly Basic Information List
Table Eli-lilly Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli-lilly Gastric Cancer Drug Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Gastric Cancer Drug Sales Market Share (2012-2017)
Table Otsuka Holdings Basic Information List
Table Otsuka Holdings Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Otsuka Holdings Gastric Cancer Drug Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Gastric Cancer Drug Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Gastric Cancer Drug Sales Market Share (2012-2017)
Table Boston Biomedical Basic Information List
Table Boston Biomedical Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boston Biomedical Gastric Cancer Drug Sales Market Share (2012-2017)
Table AROG Pharmaceuticals Basic Information List
Table AROG Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table AROG Pharmaceuticals Gastric Cancer Drug Sales Market Share (2012-2017)
Table ARIAD Pharmaceuticals Basic Information List
Table ARIAD Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table ARIAD Pharmaceuticals Gastric Cancer Drug Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Gastric Cancer Drug Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Eli Lilly Basic Information List
Table AB Science Basic Information List
Table Bayer HealthCare Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Bristol-Myers Squibb Basic Information List
Table Five Prime Basic Information List
Table BIND Therapeutics Basic Information List
Table Ipsen Biopharmaceuticals Basic Information List
Table Eddingpharm Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastric Cancer Drug
Figure Manufacturing Process Analysis of Gastric Cancer Drug
Figure Gastric Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastric Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Gastric Cancer Drug
Table Distributors/Traders List
Figure United States Gastric Cancer Drug Production and Growth Rate Forecast (2017-2022)
Figure United States Gastric Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
Table United States Gastric Cancer Drug Production Forecast by Type (2017-2022)
Table United States Gastric Cancer Drug Consumption Forecast by Application (2017-2022)
Table United States Gastric Cancer Drug Sales Forecast by States (2017-2022)
Table United States Gastric Cancer Drug Sales Share Forecast by States (2017-2022)
 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *